Autoantibodies in Sjögren's syndrome patients acutely inhibit muscarinic receptor function

Oral Diseases

Volumn 18, Issue 2, 2012, Pages 132-139

  Jin, M ^a   Hwang, S M ^a   Koo, N Y ^a   Kim, B ^a   Kho, H S ^a   Choi, S Y ^a   Song, Y W ^a   Park, K ^a  

^a Seoul National University   (South Korea)

Author keywords

Autoantibodies; Cytoplasmic free calcium; Muscarinic receptor; Potassium current; Sj gren's syndrome

Indexed keywords

ADENOSINE TRIPHOSPHATE; AUTOANTIBODY; CALCIUM; CARBACHOL; FODRIN; IMMUNOGLOBULIN G; MUSCARINIC RECEPTOR; POTASSIUM;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CONFOCAL MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOPRECIPITATION; PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL; SJOEGREN SYNDROME; SPECTROFLUOROMETRY; SUBMANDIBULAR GLAND;

AUTOANTIBODIES; CALCIUM; CALCIUM SIGNALING; CARBACHOL; CARRIER PROTEINS; CELLS, CULTURED; CHI-SQUARE DISTRIBUTION; HUMANS; IMMUNOGLOBULIN G; IMMUNOPRECIPITATION; MICROFILAMENT PROTEINS; MICROSCOPY, CONFOCAL; MICROSPECTROPHOTOMETRY; MUSCARINIC ANTAGONISTS; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; RECEPTORS, MUSCARINIC; SJOGREN'S SYNDROME; SUBMANDIBULAR GLAND;

EID: 84855923924     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2011.01853.x     Document Type: Article

References (26)

1. Bacman S, Sterin-Borda L, Camusso JJ, Arana R, Hubscher O, Borda E (1996). Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjogren's syndrome. Clin Exp Immunol 104: 454-459.
2. van Boekel MA, Vossenaar ER, van den Hoogen FH, van Venrooij WJ (2002). Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res 4: 87-93.
3. Dawson LJ, Stanbury J, Venn N, Hasdimir B, Rogers SN, Smith PM (2006). Antimuscarinic antibodies in primary Sjogren's syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells. Arthritis Rheum 54: 1165-1173.
4. Gao J, Cha S, Jonsson R, Opalko J, Peck AB (2004). Detection of anti-type 3 muscarinic acetylcholine receptor autoantibodies in the sera of Sjogren's syndrome patients by use of a transfected cell line assay. Arthritis Rheum 50: 2615-2621.
5. Goldblatt F, Gordon TP, Waterman SA (2002). Antibody-mediated gastrointestinal dysmotility in scleroderma. Gastroenterology 123: 1144-1150.
6. Haneji N, Nakamura T, Takio K et al (1997). Identification of alpha-fodrin as a candidate autoantigen in primary Sjogren's syndrome. Science 276: 604-607.
7. Hogben DN, Devey ME (1986). Studies on rheumatoid factor: I. The effect of rheumatoid factor on the clearance of preformed immune complexes in mice. Clin Exp Immunol 66: 648-653.
8. Hwang SM, Li J, Koo NY et al (2009). Role of purinergic receptor in alpha fodrin degradation in par c5 cells. J Dent Res 88: 927-932.
9. Kongo H, Hirono C, Sugita M, Iwasa Y, Shiba Y (2008). Involvement of cytoskeletal integrity in the regulation of Cl- and amylase secretion from rat parotid acinar cells. Biomed Res 29: 131-139.
10. Koo NY, Li J, Hwang SM et al (2008). Functional epitope of muscarinic type 3 receptor which interacts with autoantibodies from Sjogren's syndrome patients. Rheumatology (Oxford) 47: 828-833.
11. Li J, Ha YM, Ku NY et al (2004). Inhibitory effects of autoantibodies on the muscarinic receptors in Sjogren's syndrome. Lab Invest 84: 1430-1438.
12. Liu X, Rojas E, Ambudkar IS (1998). Regulation of KCa current by store-operated Ca2+ influx depends on internal Ca2+ release in HSG cells. Am J Physiol 275: C571-C580.
13. Liu X, Singh BB, Ambudkar IS (1999). ATP-dependent activation of K(Ca) and ROMK-type K(ATP) channels in human submandibular gland ductal cells. J Biol Chem 274: 25121-25129.
14. Lukowski S, Mira JP, Zachowski A, Geny B (1998). Fodrin inhibits phospholipases A2, C, and D by decreasing polyphosphoinositide cell content. Biochem Biophys Res Commun 248: 278-284.
15. Melvin JE, Yule D, Shuttleworth T, Begenisich T (2005). Regulation of fluid and electrolyte secretion in salivary gland acinar cells. Annu Rev Physiol 67: 445-469.
16. Newkirk MM (2002). Rheumatoid factors: host resistance or autoimmunity? Clin Immunol 104: 1-13.
17. Ohara T, Itoh Y, Itoh K (2000). Reevaluation of laboratory parameters in relation to histological findings in primary and secondary Sjogren's syndrome. Intern Med 39: 457-463.
18. Park K, Case RM, Brown PD (2001). Identification and regulation of K+ and Cl- channels in human parotid acinar cells. Arch Oral Biol 46: 801-810.
19. Perosa F, Carbone R, Ferrone S, Dammacco F (1990). Purification of human immunoglobulins by sequential precipitation with caprylic acid and ammonium sulphate. J Immunol Methods 128: 9-16.
20. Perrin D, Langley OK, Aunis D (1987). Anti-alpha-fodrin inhibits secretion from permeabilized chromaffin cells. Nature 326: 498-501.
21. Perrin D, Moller K, Hanke K, Soling HD (1992). cAMP and Ca(2+)-mediated secretion in parotid acinar cells is associated with reversible changes in the organization of the cytoskeleton. J Cell Biol 116: 127-134.
22. Popova JS, Rasenick MM (2004). Clathrin-mediated endocytosis of m3 muscarinic receptors. Roles for Gbetagamma and tubulin. J Biol Chem 279: 30410-30418.
23. Routsias JG, Tzioufas AG (2007). Sjogren's syndrome--study of autoantigens and autoantibodies. Clin Rev Allergy Immunol 32: 238-251.
24. Vitali C, Bombardieri S, Jonsson R et al (2002). Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61: 554-558.
25. Waterman SA, Gordon TP, Rischmueller M (2000). Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjogren's syndrome. Arthritis Rheum 43: 1647-1654.
26. Witte T, Matthias T, Oppermann M et al (2003). Prevalence of antibodies against alpha-fodrin in Sjogren's syndrome: comparison of 2 sets of classification criteria. J Rheumatol 30: 2157-2159.